Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of melatonin and agomelatine on sleep problems in children and adolescents with autism spectrum disorder
IRCT20230607058407N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin and agomelatine in Autism Spectrum Disorder (ASD) and sleep disorder, sponsored by Shahid Beheshti University of Medical Sciences. Started Jul 2023; status: completed.
02
Drugs
melatoninagomelatine
03
Conditions
Autism Spectrum Disorder (ASD)sleep disorder
Beyond the preview
Go deeper on IRCT20230607058407N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230607058407N1.